Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002317499 | SCV000850902 | likely benign | Inborn genetic diseases | 2021-09-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001655584 | SCV001870574 | benign | not provided | 2019-03-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001655584 | SCV002419683 | likely benign | not provided | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001655584 | SCV004811273 | likely benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | ARID1B: BS1 |
Prevention |
RCV004540024 | SCV004761835 | likely benign | ARID1B-related disorder | 2019-10-24 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |